Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: what's new 12 months later?

CONCLUSIONS: Disruption of routine healthcare services because of the pandemic translated to reduced 1 year overall and disease-free survival among patients affected by HCC, in the metropolitan area of Paris, France.PMID:37468096 | DOI:10.1016/j.aohep.2023.101141
Source: Annals of Hepatology - Category: Gastroenterology Authors: Source Type: research